Company Description
Knee surgery, no fun. Neither are operations to the eye or prostate. If biopharmaceutical company Omeros has its way, therapies it has under...
Key Omeros Financials
| Company Type | Private - NASDAQ (GM): OMER Proposed Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2006 Sales (mil.) | $0.2 |
| 2006 Employees | 62 |
More Omeros Financials (4 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Omeros's competition across multiple industries
Top Omeros Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Omeros Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman, President, CEO, and Chief Medical Officer | Gregory A. Demopulos | Network | E-mail |
| CFO and Treasurer | Richard J. Klein | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Omeros News
- BioWorld Today July 3, 2008 [BioWorld Today] (03 Jul 2008 00:01:00 EDT)
- Oil sends stocks into a second-quarter slide [Seattle Times (WA)] (01 Jul 2008 04:00:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.